EXTON, Pa. - West Pharmaceutical Services, Inc. (NYSE:WST), a company specializing in solutions for injectable drug ...

West Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and ...

West Pharmaceutical Services (NYSE:WST – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Other analysts ...

Fifth Third Bancorp lifted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 2.0% ...

Citi initiated coverage of West Pharmaceutical (WST ... The firm says the company is a “well-entrenched player” in the space for premium enhancements and devices, which the company labels ...

and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services ...

West Pharmaceutical Services Inc. closed 16.68% below its 52-week high of $413.70, which the company achieved on February 7th.

West Pharmaceutical Services stock is down 16% ... Two, valuations were, and still are, exorbitant for this company. It trades at lofty premiums (+165% on fwd EV/EBIT of 42x, +28x PEG) and this ...

The company delivered a trailing four-quarter average earnings surprise of 8.04%. West Pharmaceutical delivered better-than-expected third-quarter results, signaling resilience and recovery ...